Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Consolidated Net Income (2018 - 2023)

Historic Consolidated Net Income for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to -$14.0 million.

  • ImmunoTech's Consolidated Net Income changed N/A to -$14.0 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$14.0 million, marking a year-over-year decrease of 2183.75%. This contributed to the annual value of -$20.4 million for FY2024, which is 3621.69% up from last year.
  • As of Q4 2023, ImmunoTech's Consolidated Net Income stood at -$14.0 million.
  • Over the past 5 years, ImmunoTech's Consolidated Net Income peaked at -$3.3 million during Q3 2020, and registered a low of -$14.0 million during Q4 2023.